« Previous
Next »
Titles
- M10: bioanalytical method validation and study sample analysis : guidance for industry1
- M4 organization of the Common Technical Document for the Registration of Pharmaceuticals for Human Use1
- M4E(R2): the CTD--efficacy1
- M7(R1) assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk1
- M7(R2) assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk: guidance for industry1
- MAT for hospitalized patients1
- MAT for opioid use disorder: overcoming objections1
- MAT in community health centers1
- MAT in the emergency department: FAQ1
- MEDLARS and health information policy1
- MEDLARS classification of steroids1
- MEDLARS: the computerized literature retrieval services of the National Library of Medicine1
- MEDLARS: the world of medicine at your fingertips1
- MRI screening: what's in your pocket?1
- Madness and crime1
- Magnetic resonance (MR) receive-only coil: performance criteria for safety and performance based pathway : guidance for industry and Food and Drug Administration staff1
- Making a little go a long way: the case of Sasha Bruce Youthwork1
- Making drug costs more transparent to consumers: a summary for policymakers1
- Making education and employment work for high school students: a toolkit for systems that support young people with adult responsibilities, with benefits for all1
- Making food and nutrition security a SNAP: recommendations for the 2023 Farm Bill1